Paul H. Richardson - Plainsboro NJ Ralph M. Trksak - Manville NJ John J. Tsai - Belle Mead NJ Eric M. Weisser - Somerset NJ
Assignee:
National Starch and Chemical Investment Holding Corporation - New Castle DE
International Classification:
D21H 1912
US Classification:
162175, 162177, 162178, 1062071, 1062151, 427395
Abstract:
This invention is directed to degraded, hydrated particulate starches that are hydrophobically modified and a method of providing paper with reduced porosity, resistance to liquid penetration and increased surface strength comprising applying to the surface of a paper substrate an effective amount of a surface sizing composition which comprises such starch. In particular, the starches are those in which the starch base is degraded to a water fluidity (WF) of from about 10 to 80 or the modified and/or particulate starch is degraded using a substantially equivalent amount of degradation agent and substantially the same reaction conditions, the starch is modified with a hydrophobic hydrocarbon group of 5 to 23 carbon atoms at about 1 to 20% substitution level by weight of bound hydrophobe based on the weight of starch, and the hydrated starch has a volume average hydrated particle size of at least about 20 microns and a volume fraction of hydrated particles at 1% solids of at least about 5%.
Paul B. Foreman - Somerville NJ Paul Richardson - Plainsboro NJ John Tsai - Belle Mead NJ Jean Paul Remon - Melle, BE Jody Voorspoels - Reningelst, BE Dieter Ameye - Waregem, BE Catherine Callens - Ploegsteert, BE
Assignee:
Universiteit Gent - Ghent National Starch and Chemical Investment Holding Corporation - New Castle DE
This invention relates to a method of producing a bioadhesive composition comprising the steps of preparing a solution of a solvent and a polymer mixture wherein the polymer mixture comprises at least one natural or synthetic polycarboxylated polymer and at least one polysaccharide; drying the solution to form a solid; and heat treating the solid to effect cross-linking and to form the bioadhesive composition.
Michele M. Merrette - Bridgewater NJ, US John J. Tsai - Belle Mead NJ, US Paul H. Richardson - Plainsboro NJ, US
Assignee:
National Starch and Chemical Investment Holding Corporation - New Castle DE
International Classification:
D21H 1724
US Classification:
162175, 1062061, 536102, 536106
Abstract:
This invention relates to a degraded, inhibited cationic starch for use in papermaking systems, which affords improved physical properties, particularly strength. Additionally these derivatives provide easy-to-prepare alternatives totraditional starches, and can even be added directly to the papermaking process without cooking. While the benefits of these starch compositions can be applied to any type of papermaking method, they are especially useful in high shear, high conductivity and recycle systems.
Susan Lydzinski - Belle Mead NJ, US Todd Manegold - Somerset NJ, US Daniel Solarek - Hillsborough NJ, US John Tsai - Belle Mead NJ, US Christine Puglisi - Mountainside NJ, US
International Classification:
A61K009/70 A61K007/16 A61K031/718
US Classification:
424/443000, 514/060000
Abstract:
The present invention relates to a film, particularly an oral film, which contains starch as the main component. Such film is useful for delivering a variety of agents to humans and other animals to produce a therapeutic, organoleptic, or cosmetic effect, including breath fresheners, flavors, fragrances and pharmaceuticals.
Susan Lydzinski - Belle Mead NJ, US Todd Manegold - Somerset NJ, US Daniel Solarek - Hillsborough NJ, US John Tsai - Belle Mead NJ, US Christine Puglisi - Mountainside NJ, US
International Classification:
A61K007/16 A61K009/70 A61K031/718
US Classification:
424/443000, 514/060000
Abstract:
The present invention relates to a film, particularly an oral film, which contains starch as the main component. Such film is useful for delivering a variety of agents to humans and other animals to produce a therapeutic, organoleptic, pharmacological, agricultural or cosmetic effect, including breath fresheners, flavors, fragrances and pharmaceuticals.
Polysaccharide Derivatives Containing Aldehyde Groups, Their Preparation From The Corresponding Acetals And Use As Paper Additives
Daniel B. Solarek - Somerville NJ Patrick G. Jobe - Westfield NJ Martin M. Tessler - Edison NJ Robert L. Billmers - Stockton NJ Diane J. Lamb - Bound Brook NJ John J. Tsai - Belle Mead NJ
Assignee:
National Starch and Chemical Corporation - Bridgewater NJ
International Classification:
D21H 320
US Classification:
162175
Abstract:
Polysaccharide aldehydes having the formula ##STR1## starch, cellulose, and gum aldehydes, are useful for imparting wet, dry, or temporary wet strength to paper. They are prepared by a non-oxidative method which involves reacting the polysaccharide base, in the presence of alkali, with a derivatizing acetal reagent having the general structure ##STR2## and then hydrolyzing the acetal by adjusting the pH to less than 7, preferably 2-4. In the formula, n is 1-3; R. sup. 11 and R. sup. 12 are independently an alkyl, aryl, aralkyl, or alkaryl group when n is 1, R. sup. 11 or R. sup. 12 is one of the groups when n is 2, or R. sup. 11 and R. sup. 12 are not present when n is 3; R. sup. 13 is an alkyl group, optionally containing an ether linkage, or an aryl, aralkyl, or alkaryl group; R. sup. 14 and R. sup. 15 are individually a hydrogen or a methyl group; R. sup. 16, R. sup. 17, and R. sup.
Acetals Useful For The Preparation Of Polysaccharide Derivatives
Daniel B. Solarek - Somerville NJ Patrick G. Jobe - Westfield NJ Martin M. Tessler - Edison NJ Robert L. Billmers - Stockton NJ Diane J. Lamb - Bound Brook NJ John J. Tsai - Belle Mead NJ
Assignee:
National Starch and Chemical Corporation - Bridgewater NJ
International Classification:
C07D31906
US Classification:
549374
Abstract:
Polysaccharide aldehydes having the formula Sacch-O-CH. sub. 2 -CH. dbd. CH-CHO, Sacch-O-CH. sub. 2 -C. tbd. C-CHO, ##STR1## such as starch, cellulose, and gum aldehydes, are useful for imparting wet, dry, or temporary wet strength to paper. They are prepared by a non-oxidative method which involves reacting the polysaccharide base, in the presence of alkali, with a derivatizing acetal reagent having the general structure ##STR2## and then hydrolyzing the acetal by adjusting the pH to less than 7, preferably 2-4. In the formulas, n is 1-3; R. sup. 11 and R. sup. 12 are independently an alkyl, aryl, aralkyl, or alkaryl group when n is 1, R. sup. 11 or R. sup. 12 is one of the groups when n is 2, or R. sup. 11 and R. sup. 12 are not present when n is 3; R. sup. 13 is an alkyl group, optionally containing an ether linkage, or an aralkyl group; R. sup. 14 and R. sup.
Paul B. Foreman - Somerville NJ Paul Richardson - Plainsboro NJ John Tsai - Belle Mead NJ Jean Paul Remon - Melle, BE Jody Voorspoels - Reningelst, BE Dieter Ameye - Waregem, BE Catherine Callens - Ploegsteert, BE
Assignee:
National Starch and Chemical Company Investment Holding Corporation - Wilmington DE
International Classification:
A61K 3174
US Classification:
424 7808
Abstract:
This invention relates to a method of producing a bioadhesive composition comprising the steps of preparing a solution of a solvent and a polymer mixture wherein the polymer mixture comprises at least one natural or synthetic polycarboxylated polymer and at least one polysaccharide; drying the solution to form a solid; and heat treating the solid to effect cross-linking and to form the bioadhesive composition.
Medicine Doctors
Dr. John Tsai, Plainsboro NJ - MD (Doctor of Medicine)
Dr. Tsai graduated from the Northwestern University Feinberg School of Medicine in 2001. He works in Tucson, AZ and 1 other location and specializes in Gastroenterology. Dr. Tsai is affiliated with Carondelet Saint Josephs Hospital and Cornerstone Hospital Of Southeast Arizona.
Dr. Tsai graduated from the George Washington University School of Medicine and Health Science in 1998. He works in Centreville, VA and 1 other location and specializes in Pediatrics and Adolescent Medicine. Dr. Tsai is affiliated with Inova Fair Oaks Hospital.
Dr. Tsai graduated from the Ohio State University College of Medicine in 1987. He works in Massillon, OH and specializes in Cardiovascular Disease. Dr. Tsai is affiliated with Mercy Medical Center.
Kaiser Permanente Medical GroupKaiser Permanente Anesthesiology 9300 Imperial Hwy, Downey, CA 90242 (562)4613000 (phone), (562)6579953 (fax)
Education:
Medical School Albert Einstein College of Medicine at Yeshiva University Graduated: 1997
Languages:
English
Description:
Dr. Tsai graduated from the Albert Einstein College of Medicine at Yeshiva University in 1997. He works in Downey, CA and specializes in Pediatric Anesthesiology.
nchise and Global Head of Medical Affairs for the Pharmaceuticals business unit. Dr. Aradhye will report to Vas Narasimhan and join the ECN. With the changes in organizational structure and operating model, John Tsai, M.D., has decided to pursue opportunities outside Novartis effective May 15th, 2022.
Date: Apr 04, 2022
Category: Business
Source: Google
Novartis to test hydroxychloroquine for coronavirus
We recognise the importance of answering the scientific question of whether hydroxychloroquine will be beneficial for patients with COVID-19 disease, said John Tsai, head of Global Drug Development and chief medical officer at Novartis. We mobilised quickly to address this question in a randomise